article thumbnail

Damage to the heart found in more than half of COVID-19 patients discharged from hospital

Scienmag

Credit: European Heart Journal Around 50% of patients who have been hospitalised with severe COVID-19 and who show raised levels of a protein called troponin have damage to their hearts.

Protein 98
article thumbnail

Study estimates exposure to air pollution increases COVID-19 deaths by 15% worldwide

Scienmag

Credit: European Heart Journal Long-term exposure to air pollution has been linked to an increased risk of dying from COVID-19 and, for the first time, a study has estimated the proportion of deaths from the coronavirus that could be attributed to the exacerbating effects of air pollution for every country in the world. The study, […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study examines aspirin and statin use among older Americans

Scienmag

An analysis published in the Journal of the American Geriatrics Society indicates that while adults aged 75 years and older do not benefit from taking aspirin to prevent cardiovascular disease, many do so on a regular basis.

article thumbnail

New analysis examines survival of older patients who undergo heart transplantation

Scienmag

Advanced age is often considered a contraindication for heart transplantation, but a new study published in the Journal of the American Geriatrics Society (JAGS) found that post-heart transplant survival among recipients aged ?70 70 years is not inferior to that of younger recipients.

article thumbnail

2021 INS Standards highlight anti-reflux technology for needleless connectors

Scienmag

Significant patient safety issues linked to blood reflux in vascular access devices, including catheter occlusions, failure and infections Credit: Lee Steere, RN, CRNI, VA-BC Lenexa, Kan.

Nurses 69
article thumbnail

Existing heart drugs may help cancer patients respond better to PD(L)1 immunotherapy

Scienmag

Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses to anti-cancer immunotherapies called PD(L)1 inhibitors, according to preliminary findings to be presented at the 32th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online.

Drugs 73
article thumbnail

COVID-19 patients suffer long-term lung and heart damage but it can improve with time

Scienmag

Coronavirus patients recover faster if they undergo rehabilitation as soon as possible after coming off ventilators or leaving intensive care Credit: Gerlig Widmann and team, Department of Radiology, Medical University of Innsbruck.